Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · Real-Time Price · USD
0.9811
-0.0164 (-1.64%)
At close: Aug 13, 2025, 4:00 PM
0.9801
-0.0010 (-0.10%)
Pre-market: Aug 14, 2025, 8:19 AM EDT
Lucid Diagnostics Market Cap
Lucid Diagnostics has a market cap or net worth of $99.97 million as of August 14, 2025. Its market cap has increased by 121.76% in one year.
Market Cap
99.97M
Enterprise Value
95.26M
1-Year Change
121.76%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since the IPO on October 14, 2021, Lucid Diagnostics's market cap has decreased from $514.14M to $99.97M, a decrease of -80.56%. That is a compound annual growth rate of -34.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 101.64M | 123.91% |
| Dec 31, 2024 | 45.39M | -23.95% |
| Dec 29, 2023 | 59.69M | 12.22% |
| Dec 30, 2022 | 53.19M | -73.09% |
| Dec 31, 2021 | 197.66M | -61.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 589.14B |
| Johnson & Johnson | 419.00B |
| AbbVie | 355.15B |
| UnitedHealth Group | 244.71B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 225.27B |
| Novo Nordisk | 223.00B |